Dr. Reddy's Laboratories Ltd (RDY) Social Stream
DR REDDYS LABORATORIES LTD (RDY) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering DR REDDYS LABORATORIES LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 2 | $80 | $75.7 | $77.85 | $55.12 | 41.24% |
| 2022-01-06 | 2 | $80 | $75.5 | $77.75 | $55.12 | 41.06% |
| 2022-01-28 | 1 | $80 | $68.5 | $74.25 | $55.12 | 34.71% |
| 2022-03-30 | 1 | $80 | $66.4 | $73.2 | $55.12 | 32.8% |
| 2022-04-28 | 1 | $69 | $66.4 | $67.7 | $55.12 | 22.82% |
| 2022-05-19 | 2 | $69 | $59 | $64.8 | $55.12 | 17.56% |
| 2022-06-21 | 3 | $70 | $59 | $64.8 | $55.12 | 17.56% |
| 2022-07-25 | 3 | $68 | $59 | $65 | $55.12 | 17.92% |
| 2022-08-13 | 3 | $68 | $57 | $63.666 | $55.12 | 15.5% |
| 2022-09-17 | 3 | $69 | $57 | $64 | $55.12 | 16.11% |
| 2022-10-13 | 3 | $69 | $57 | $63.033 | $55.12 | 14.36% |
| 2022-10-25 | 3 | $66.001 | $57 | $62.033 | $55.12 | 12.54% |
| 2022-10-30 | 3 | $66.001 | $57 | $61.5 | $55.12 | 11.57% |
| 2023-01-05 | 3 | $67 | $57 | $62.266 | $55.12 | 12.96% |
| 2023-01-27 | 3 | $67 | $57 | $61.5 | $55.12 | 11.57% |
| 2023-02-27 | 4 | $67 | $57 | $61.533 | $55.12 | 11.63% |
| 2023-03-16 | 4 | $67 | $60.6 | $62.866 | $55.12 | 14.05% |
The Trend in the Analyst Price Target
Over the past 17 months, RDY's average price target has gone down $14.98.
Over the past 50 weeks, RDY's average upside potential has been 19.44%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-30 | 1 | 80 | 66.4 | 73.200 | 56.64 | 29.24% |
| 2022-05-19 | 3 | 69 | 59.0 | 64.800 | 51.35 | 26.19% |
| 2022-06-21 | 3 | 70 | 59.0 | 64.800 | 55.10 | 17.6% |
| 2022-07-28 | 3 | 68 | 57.0 | 63.666 | 52.33 | 21.66% |
| 2023-01-27 | 3 | 67 | 57.0 | 61.533 | 53.34 | 15.36% |
RDY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 3 | 0 | 0 | 1 | 1 | 4 |
The Trend in the Broker Recommendations
RDY's average broker recommendation rating worsened by 1 over the prior 52 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, DR REDDYS LABORATORIES LTD's number of analysts covering the stock is higher than 133.3% of them.
- DR REDDYS LABORATORIES LTD's variance in analysts' estimates is lower than -22.71% of stocks in the large market cap category.
- DR REDDYS LABORATORIES LTD's upside potential (average analyst target price relative to current price) is greater than 275.85% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, DR REDDYS LABORATORIES LTD's average analyst price target is greater than 1550.21% of them.
In the Pharmaceutical Products industry, BGNE, GSK, and GRFS are the three stocks most similar to DR REDDYS LABORATORIES LTD regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RDY a Buy, Hold or Sell? See the POWR Ratings now!